Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells.

Cui XY, Skretting G, Jing Y, Sun H, Sandset PM, Sun L.

Blood Cells Mol Dis. 2013 Oct;51(3):177-84. doi: 10.1016/j.bcmd.2013.05.003. Epub 2013 May 29.

PMID:
23725749
[PubMed - indexed for MEDLINE]
2.

Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.

Cheng Z, Yang N, Liang W, Yan X, Li L, Pan L.

Leuk Lymphoma. 2012 Jul;53(7):1383-9. doi: 10.3109/10428194.2011.650695. Epub 2012 Jan 31.

PMID:
22185283
[PubMed - indexed for MEDLINE]
3.

Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines.

Marques DS, Sandrini JZ, Boyle RT, Marins LF, Trindade GS.

Leuk Res. 2010 Jun;34(6):757-62. doi: 10.1016/j.leukres.2009.11.004. Epub 2009 Dec 6.

PMID:
19969351
[PubMed - indexed for MEDLINE]
4.

Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.

Zhang Y, Qu XJ, Liu YP, Yang XH, Hou KZ, Teng YE, Zhang JD.

Ai Zheng. 2009 Feb;28(2):97-9. Epub 2009 Feb 23.

PMID:
19550116
[PubMed - indexed for MEDLINE]
5.

Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.

Martin-Aragon S, Mukherjee SK, Taylor BJ, Ivy SP, Fu CH, Ardi VC, Avramis VI.

Anticancer Res. 2000 Jan-Feb;20(1A):139-50.

PMID:
10769646
[PubMed - indexed for MEDLINE]
6.

Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.

Herrmann H, Blatt K, Shi J, Gleixner KV, Cerny-Reiterer S, Müllauer L, Vakoc CR, Sperr WR, Horny HP, Bradner JE, Zuber J, Valent P.

Oncotarget. 2012 Dec;3(12):1588-99.

PMID:
23249862
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

[The relationship between multi-drug resistance and proportion of leukemia stem cells and expression of drug transporters in drug-resistant leukemia K562/ADM cells].

Yi J, Chen J, Sun J, Wei HL.

Zhonghua Yi Xue Za Zhi. 2009 Jul 7;89(25):1741-4. Chinese.

PMID:
19862976
[PubMed - indexed for MEDLINE]
8.

Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells.

Misra R, Sahoo SK.

Mol Pharm. 2011 Jun 6;8(3):852-66. doi: 10.1021/mp100455h. Epub 2011 Apr 15. Erratum in: Mol Pharm. 2013 Dec 2;10(12):4746.

PMID:
21480667
[PubMed - indexed for MEDLINE]
9.

Expression profile of Notch-related genes in multidrug resistant K562/A02 cells compared with parental K562 cells.

Yan S, Ma D, Ji M, Guo D, Dai J, Zhao P, Ji C.

Int J Lab Hematol. 2010 Apr;32(2):150-8. doi: 10.1111/j.1751-553X.2009.01149.x. Epub 2009 Mar 12.

PMID:
19302234
[PubMed - indexed for MEDLINE]
10.

Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.

den Boer ML, Pieters R, Kazemier KM, Rottier MM, Zwaan CM, Kaspers GJ, Janka-Schaub G, Henze G, Creutzig U, Scheper RJ, Veerman AJ.

Blood. 1998 Mar 15;91(6):2092-8.

PMID:
9490695
[PubMed - indexed for MEDLINE]
Free Article
11.
12.

TGF beta-induced SMAD2 phosphorylation predicts inhibition of thymidine incorporation in CD34+ cells from healthy donors, but not from patients with AML after MDS.

Koschmieder S, Hofmann WK, Kunert J, Wagner S, Ballas K, Seipelt G, Hoelzer D, Ottmann OG, Kalina U.

Leukemia. 2001 Jun;15(6):942-9.

PMID:
11417481
[PubMed - indexed for MEDLINE]
13.

High concentrations of L-ascorbic acid specifically inhibit the growth of human leukemic cells via downregulation of HIF-1α transcription.

Kawada H, Kaneko M, Sawanobori M, Uno T, Matsuzawa H, Nakamura Y, Matsushita H, Ando K.

PLoS One. 2013 Apr 23;8(4):e62717. doi: 10.1371/journal.pone.0062717. Print 2013.

PMID:
23626851
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia.

Raaijmakers MH, de Grouw EP, Heuver LH, van der Reijden BA, Jansen JH, Scheper RJ, Scheffer GL, de Witte TJ, Raymakers RA.

Clin Cancer Res. 2005 Mar 15;11(6):2436-44.

PMID:
15788695
[PubMed - indexed for MEDLINE]
Free Article
15.

Hypoxia selects bortezomib-resistant stem cells of chronic myeloid leukemia.

Tanturli M, Giuntoli S, Barbetti V, Rovida E, Dello Sbarba P.

PLoS One. 2011 Feb 11;6(2):e17008. doi: 10.1371/journal.pone.0017008.

PMID:
21347297
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin.

Yang CZ, Luan FJ, Xiong DS, Liu BR, Xu YF, Gu KS.

Zhongguo Yao Li Xue Bao. 1995 Jul;16(4):333-7.

PMID:
7668104
[PubMed - indexed for MEDLINE]
Free Article
17.

The Hsp90 inhibitor SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells through suppression of Akt/NF-κB and disruption of mitochondria-dependent pathways.

Wang R, Shao F, Liu Z, Zhang J, Wang S, Liu J, Liu H, Chen H, Liu K, Xia M, Wang Y.

Chem Biol Interact. 2013 Sep 5;205(1):1-10. doi: 10.1016/j.cbi.2013.06.007. Epub 2013 Jun 15.

PMID:
23777986
[PubMed - indexed for MEDLINE]
18.

Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.

Marone M, Scambia G, Bonanno G, Rutella S, de Ritis D, Guidi F, Leone G, Pierelli L.

Leukemia. 2002 Jan;16(1):94-105.

PMID:
11840268
[PubMed - indexed for MEDLINE]
Free Article
19.

Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.

Mimeault M, Batra SK.

J Cell Mol Med. 2013 Jan;17(1):30-54. doi: 10.1111/jcmm.12004. Epub 2013 Jan 10.

PMID:
23301832
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.

Ma L, Lai D, Liu T, Cheng W, Guo L.

Acta Biochim Biophys Sin (Shanghai). 2010 Sep;42(9):593-602. doi: 10.1093/abbs/gmq067. Epub 2010 Aug 12.

PMID:
20705681
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk